DOLCEPHARMA
Sources: the KBO register on 18-11-2026; the National Bank, 2025 annual accounts filed on 29-06-2026; the Belgian Official Gazette, latest deed of 22-10-2019.
Grounds
the facts the verdict rests on, each with its source- In 2025, DOLCEPHARMA closed with a net profit of €17,393.Annual accounts 2025 page 2
- Equity stands at €197,065, or 64.6% of the balance sheet total of €304,973. That is more than 76% of the 15,503 companies in the wholesale trade sector (NACE 46).Annual accounts 2025 page 2
- The 2025 accounts reached the National Bank 32 days before the end of the term.National Bank, filing of 29-06-2026 page 5
- (0831.387.295) holds 99.46% of the shares. Its equity stood at €541,471 on 30-06-2025.Annual accounts 30-06-2025 of page 3
Representation
The signing rule is in the deed of 22-10-2019.
Articles of association, Belgian Official Gazette of 22-10-2019, deed 19340119
Ownership
(0831.387.295) holds 99.46% of the shares. Its equity stood at €541,471 on 30-06-2025.
Annual accounts 30-06-2025 of
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Gross margin and net resultin euro
Equity and debtsin euro
Cashin euro
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €151,979 | €135,757 | €150,017 | €173,620 | €166,450 | |
| Operating result | €36,810 | €34,029 | €27,139 | €15,866 | -€14,769 | |
| Net result | €33,645 | €36,955 | €47,470 | €40,080 | €17,393 | |
| Balance sheet at the closing date | ||||||
| Equity | €175,166 | €152,122 | €159,592 | €179,672 | €197,065 | |
| Debts | €71,657 | €169,543 | €141,116 | €163,356 | €107,909 | |
| Debts due within one year | €64,008 | €159,538 | €126,549 | €159,947 | €104,569 | |
| Cash | €62,137 | €129,262 | €95,452 | €119,050 | €70,844 | |
| Balance sheet total | €246,824 | €321,664 | €300,708 | €343,028 | €304,973 | |
| Operations | ||||||
| Employees in full-time equivalents | 1.9 | 1.5 | 1.8 | 1.8 | 1.8 | |
| Ratios | ||||||
| Solvency | 71.0% | 47.3% | 53.1% | 52.4% | 64.6% | |
| Liquidity | 3.75 | 1.93 | 2.30 | 2.09 | 2.83 | |
Source: Annual accounts 2025, micro format, filed on 29-06-2026 (2026-00224826); Annual accounts 2024, micro format, filed on 26-06-2025 (2025-00183688); Annual accounts 2021 to 2023, filed from 25-08-2022 to 09-08-2024 (2022-20382532, 2023-00458408, 2024-00337708).
Debts fell by €55,448 in 2025.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
DOLCEPHARMA states no turnover; the micro format does not require it. The gross margin, what is left after purchases, fell from €173,620 to €166,450.
Board, signature and ownership
Position on 18-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The signing rule is in the deed of 22-10-2019.
Articles of association, Belgian Official Gazette of 22-10-2019, deed 19340119
Board
one director in officeOwnership and group
Shareholders
(0831.387.295) holds 99.46% of the shares. Its equity stood at €541,471 on 30-06-2025.
Annual accounts 30-06-2025 of
Board changes
changes role from manager to niet statutaire zaakvoerder van de bvba. resigns as manager. Director discharge: . Legal-form conversion: from private limited company (pre-2019) to private limited company. General meeting of 01-04-2019.
Gazette, deed 19340119New manager. appointed, resigned. General meeting of 01-04-2019.
Gazette, deed 19052352Group
has 1 direct subsidiary (accounts to 30-06-2025).
| Country | Company | Equity | Result | |
|---|---|---|---|---|
| Belgium 1 | ||||
| BE | Dolcepharmathis company99.46% | €197,065 | result €17,393 | |
Source: List of holdings in the accounts to 30-06-2025 of . Every holding stands with its own latest accounts.
Events and comparison
The latest events, newest first
Annual accounts 2025 filed, 32 days before the deadline.
NBB filingRegistered in the Peppol Directory. Reachable for e-invoices through 0208:0865158341.
Annual accounts 2024 filed, 35 days before the deadline.
NBB filingAnnual accounts 2023 filed, 9 days late.
NBB filingHighest result from 2006 to 2025. The net result of €47,470 is the highest of those years.
FinancialAnnual accounts 2022 filed, 57 days late.
NBB filingAnnual accounts 2021 filed, 25 days late.
NBB filingEquity above €150,000. After 12 profitable years in a row, equity reaches €175,166.
FinancialAnnual accounts 2020 filed, 39 days late.
NBB filingAnnual accounts 2019 filed, 32 days before the deadline.
NBB filingchanges role from manager to niet statutaire zaakvoerder van de bvba. resigns as manager. Director discharge: . Legal-form conversion: from private limited company (pre-2019) to private limited company. General meeting of 01-04-2019.
Gazette, deed 19340119Annual accounts 2018 filed, 28 days late.
NBB filingNew manager. appointed, resigned. General meeting of 01-04-2019.
Gazette, deed 19052352Annual accounts 2017 filed, 31 days late.
NBB filingComparable companies, two years later
In July 2024, 31,389 companies had the same profile as DOLCEPHARMA has now: micro, 20 years or older, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 93.4% were still trading, 6.1% had stopped another way and 0.5% had gone bankrupt.
In 2025, DOLCEPHARMA had a higher net result than 67% of the 15,467 companies in the wholesale trade sector (NACE 46).
Other findings
Peppol
Reachable for e-invoices since 22-12-2025, under 0208:0865158341.
Sanctions lists
Staff
2 employees on 31-12-2025, 1.8 full-time equivalents on average over the year.
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 18-11-2026 | KBO 0865.158.341 |
| National Bank of Belgium | Annual accounts 2025, micro format | 29-06-2026 | 2026-00224826 |
| National Bank of Belgium | Annual accounts 2024, micro format | 26-06-2025 | 2025-00183688 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 25-08-2022 to 09-08-2024 | 2022-20382532, 2023-00458408, 2024-00337708 |
| Belgian Official Gazette | Articles of association with the signing rule | 22-10-2019 | deed 19340119 |
| Belgian Official Gazette | Board | 16-04-2019 | deed 19052352 |
| Peppol Directory | Registration for e-invoices | 22-12-2025 | 0208:0865158341 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 16-11-2026 | no match |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 17-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 17-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.